NMC
WX

Nine Masts Capital’s WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS WX Stock Holding History

Nine Masts Capital’s Portfolio WX Stock Details WX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		– Sell
-525,985
Closed -$22.7M – 101
2015
Q3 		$22.7M Buy
525,985
+386,185
+276% +$16.3M 5.83% 6
2015
Q2 		$5.91M Buy
+139,800
New +$5.9M 1.94% 13

Other funds holding WX

Ninety One (UK)
Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return
CCS
Crosspoint Capital Strategies Orinda, California $50.4M AUM 15.37% 1-Year Est. Return

Nine Masts Capital's WX Position: Q4 2015 in Review

Nine Masts Capital sold out of WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS (WX) in Q4 2015, closing a stake of 525,985 shares — an estimated $22.7M sold.

Nine Masts Capital first reported a position in WX in Q2 2015 and held it in 2 quarters. The position peaked at $22.7M in Q3 2015. 2 funds tracked by Wall St. Rank hold WX as of Q4 2015.

  • Nine Masts Capital reported no remaining WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS position as of Q4 2015 after selling out during the quarter.
  • Nine Masts Capital sold 525,985 WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS shares in Q4 2015, an estimated $22.7M.
  • Nine Masts Capital first reported a position in WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS in Q2 2015 and held it in 2 quarters.
  • Nine Masts Capital's WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS position peaked at $22.7M in Q3 2015.
  • 2 funds tracked by Wall St. Rank held WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS as of Q4 2015.

Based on Nine Masts Capital's 13F filing for Q4 2015, filed 16 Feb 2016.